SCHOLAR ROCK HLDG CORP's ticker is SRRK and the CUSIP is 80706P103. A total of 102 filers reported holding SCHOLAR ROCK HLDG CORP in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,948,200 | +5.3% | 243,525 | +19.2% | 0.00% | 0.0% |
| Q4 2022 | $1,849,684 | +20.6% | 204,385 | -7.6% | 0.00% | +33.3% |
| Q3 2022 | $1,534,000 | -9.3% | 221,279 | -28.2% | 0.00% | 0.0% |
| Q2 2022 | $1,691,000 | +102.8% | 307,978 | +375.7% | 0.00% | +50.0% |
| Q1 2022 | $834,000 | -3.7% | 64,740 | +146.9% | 0.00% | -50.0% |
| Q3 2021 | $866,000 | +223.1% | 26,217 | +395.1% | 0.00% | +300.0% |
| Q1 2021 | $268,000 | -42.6% | 5,295 | -44.9% | 0.00% | -66.7% |
| Q4 2020 | $467,000 | +476.5% | 9,615 | +55.9% | 0.00% | +200.0% |
| Q4 2019 | $81,000 | -91.2% | 6,169 | -94.0% | 0.00% | -85.7% |
| Q3 2019 | $918,000 | -12.3% | 102,455 | +55.3% | 0.01% | -22.2% |
| Q2 2019 | $1,047,000 | -20.9% | 65,978 | -6.4% | 0.01% | +50.0% |
| Q1 2019 | $1,324,000 | +8.9% | 70,514 | -9.5% | 0.01% | -66.7% |
| Q2 2018 | $1,216,000 | – | 77,930 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 2,450,000 | $31,581,000 | 1.32% |
| Logos Global Management LP | 675,000 | $8,701,000 | 1.13% |
| Samsara BioCapital, LLC | 339,611 | $4,378,000 | 1.10% |
| Redmile Group, LLC | 2,407,326 | $31,030,000 | 0.97% |
| Bellevue Group AG | 2,184,425 | $28,157,000 | 0.33% |
| Frazier Life Sciences Management, L.P. | 156,000 | $2,011,000 | 0.17% |
| Atom Investors LP | 25,839 | $333,000 | 0.16% |
| GSA CAPITAL PARTNERS LLP | 32,010 | $413,000 | 0.06% |
| Tekla Capital Management LLC | 108,833 | $1,403,000 | 0.05% |
| Virtus ETF Advisers LLC | 6,212 | $80,000 | 0.04% |